Prevalence and 11-year Incidence of Common Eye Diseases and Their Relation to Health-related Quality of Life, Mental Health, and Visual Impairment
Overview
Rehabilitation Medicine
Authors
Affiliations
Purpose: To study the prevalence and incidence of the most common eye diseases and their relation to health-related quality of life (HRQoL), depression, psychological distress, and visual impairment in the aging population of Finland.
Methods: Our study was based on two nationwide health surveys conducted in 2000 and 2011. Eye disease status data were obtained from 7379 and 5710 individuals aged 30 + years, of whom 4620 partook in both time points. Both surveys included identical indicators of HRQoL (EuroQol-5 Dimension [EQ-5D], 15D), depression (Beck Depression Inventory [BDI]), psychological distress (General Health Questionnaire-12 [GHQ-12]), visual acuity, and self-reported eye diseases. We assessed the impact of known eye diseases on these factors, adjusted for age, gender, and co-morbidities.
Results: Prevalence of self-reported eye diseases was 3.1/2.7% for glaucoma, 8.1/11.4% for cataract, and 3.4/3.8% for retinal degeneration in 2000 and 2011, and the average incidence between 2000 and 2011 was 22, 109, and 35 /year/10,000 individuals, respectively. These eye diseases were associated with a significant decrease in EQ-5D and 15D index scores in both time points. BDI and GHQ-12 scores were also worsened, with some variation between different eye diseases. Impaired vision was, however, the strongest determinant of declined HRQoL. During the 11-year follow-up the effect of eye diseases on HRQoL and mental health diminished.
Conclusion: Declined HRQoL associated with eye diseases is more related to impaired vision than the awareness of the disease itself, and this declining effect diminished during the follow-up. Therefore, information directed to the public on the risks and prevention of blindness can and should be strengthened to prevent the deleterious effects of visual impairment.
Cai C, Shuai Y, Li G BMC Ophthalmol. 2025; 25(1):20.
PMID: 39815249 PMC: 11734459. DOI: 10.1186/s12886-025-03864-9.
Targeting ocular tissues with intravenously administered aptamers selected by SELEX.
Korhonen S, Stenberg K, Seemab U, Bartos P, Makiniemi K, Kjems J Mol Ther Nucleic Acids. 2024; 35(4):102352.
PMID: 39469668 PMC: 11513532. DOI: 10.1016/j.omtn.2024.102352.
Pablo L, Garay-Aramburu G, Garcia Layana A, Fernandez A, Vazquez I, Acebes X Health Econ Rev. 2024; 14(1):70.
PMID: 39225974 PMC: 11370269. DOI: 10.1186/s13561-024-00546-y.
Kubin A, Korva-Gurung I, Ohtonen P, Hautala N J Patient Rep Outcomes. 2024; 8(1):89.
PMID: 39133415 PMC: 11319536. DOI: 10.1186/s41687-024-00775-z.
Diagnostic performance of light reflex pupillometry in Alzheimer's disease.
Gramkow M, Clemmensen F, Sjaelland N, Waldemar G, Hasselbalch S, Frederiksen K Alzheimers Dement (Amst). 2024; 16(3):e12628.
PMID: 39086497 PMC: 11289725. DOI: 10.1002/dad2.12628.